Home
News
Create
Screeners
Insights
Mahamaya Lifesciences
140.
95
-2.05
(-1.43%)
Market Cap
₹329.90 Cr
PE Ratio
25.86
Industry
Chemicals
Buy
Sell
Company Performance:
1D
-1.43%
1M
-20.41%
6M
+21.51%
1Y
+21.51%
5Y
+21.51%
View Company Insights
Latest news about Mahamaya Lifesciences
Mahamaya Lifesciences Extends IPO Proceeds Utilisation Timeline to March 2028
10 days ago
Mahamaya Lifesciences Limited has extended its IPO proceeds utilisation timeline to March 2028, with Rs. 3449.03 lakhs remaining unutilised from total net proceeds of Rs. 6196.43 lakhs. The board-approved extension addresses technical execution factors for manufacturing plant implementation, including engineering cycles and equipment procurement timelines. The company confirmed no changes to project scope or objects of issue as disclosed in its November 2025 prospectus.
Mahamaya Lifesciences Withdraws from Arihant Capital Virtual Conference Due to Scheduling Constraints
Mar 09, 2026
Mahamaya Lifesciences Limited Receives 'Company of the Year – Medium Scale' Award at ICSCE 2026, Dubai
Jan 22, 2026
Vijay Kedia Acquires 8.91 Lakh Shares in Mahamaya Lifesciences at ₹140 Per Share
Dec 17, 2025
Mahamaya Lifesciences Reports 17.6% Profit Growth in H1 FY26
Dec 02, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO